Laxxon Medical to Participate in 22nd Annual Needham Virtual Healthcare Conference

NEW YORK, NY / ACCESSWIRE / April 17, 2023 / Laxxon Medical announced today their participation in the 22nd Annual Needham Virtual Healthcare Conference from Monday, April 17^th to Thursday, April 20^th. Laxxon CEO Helmut Kerschbaumer will present on Thursday, April 20^th at 9:30A.M. ET. The live webcast link can be accessed on the "Investors" page at www.laxxonmedical.com. A replay of the webcast will be available on the Laxxon website following the presentation.

About Laxxon Medical Corporation

Laxxon Medical is a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions through SPID®-Technology (Screen Printing Innovational Drug Technology), an additive 3D screen printing technology and manufacturing process. Laxxon Medical holds the exclusive worldwide rights to the use and application of SPID®-Technology for the development, manufacture, and commercialization of pharmaceutical dosage forms.

For more information, visit www.laxxonmedical.com or follow Laxxon Medical on LinkedIn or Twitter.

Investor Contact:

Frances Hoggard
Communications Manager
f.hoggard@laxxonmedical.com

SOURCE: Laxxon Medical